UK is first European country to approve Eisai and Biogen's Alzheimer's drug Leqembi, after EU advisors say safety concerns outweigh its benefits.

In the fascinating tapestry of human life, one of the most enduring and often perplexing threads is the aging process. It has ...

New research results reported at the Alzheimer’s Association International Conference in Toronto advanced scientific understanding of risk, diagnosis and treatment of Alzheimer’s disease and other ...